Notably, blocking ASIC1a with an amiloride derivative benzamil was able to alleviate pathology through reduction of Huntingtin–polyglutamine aggregation, the HD hallmark in the striatum of R6/2 mice model of HD (Wong et al., 2008). This evidence concerns the gene HTT and Huntington disease.